Blood-Brain Barrier In Vitro Models and Their Application in Toxicology: The Report and Recommendations of ECVAM Workshop 491,2

Blood-brain barrier in vitro models and their application in toxicology. The report and recommendations of ECVAM Workshop 49.

[1]  J. Ghersi-Egea,et al.  Demonstration of a Coupled Metabolism–Efflux Process at the Choroid Plexus as a Mechanism of Brain Protection Toward Xenobiotics , 1999, The Journal of Neuroscience.

[2]  A. Strosberg,et al.  Regulation of gamma‐glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells , 1994, Journal of cellular physiology.

[3]  N. Tandon,et al.  Plasmodium falciparum: involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells. , 1996, Experimental parasitology.

[4]  P. Friedl,et al.  Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. , 1996, Experimental cell research.

[5]  L. Fenart,et al.  In vitro model for evaluating drug transport across the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[6]  J. DeJongh,et al.  Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  T. Terasaki,et al.  Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. , 2001, Biological & pharmaceutical bulletin.

[8]  J. Ghersi-Egea,et al.  Choroid Plexus Transporters for Drugs and Other Xenobiotics , 2002, Journal of drug targeting.

[9]  J. Tonn,et al.  Characteristic gene expression profile of primary human cerebral endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  H. Galla,et al.  Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. , 1998, Biochemical and biophysical research communications.

[11]  P Delorme,et al.  An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.

[12]  C. Catania,et al.  Neurons and ECM regulate occludin localization in brain endothelial cells , 2000, Neuroreport.

[13]  M. Schroeter,et al.  *NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. , 2001, Microvascular research.

[14]  K. Krishnan,et al.  A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals. , 1996, Toxicology and applied pharmacology.

[15]  B. McEwen,et al.  Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.

[16]  M. Dehouck,et al.  Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier , 1995 .

[17]  L. Rubin,et al.  The cell biology of the blood-brain barrier. , 1999, Annual review of neuroscience.

[18]  M E Andersen,et al.  Physiological modelling of organic compounds. , 1991, The Annals of occupational hygiene.

[19]  M. Dehouck,et al.  Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. , 1996, The American journal of physiology.

[20]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[21]  D. Scherman,et al.  Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. , 1995, Experimental cell research.

[22]  N. Yamamoto,et al.  Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors , 1999, Neuroscience Research.

[23]  M. Dehouck,et al.  Endothelin-1 as a Mediator of Endothelial Cell–Pericyte Interactions in Bovine Brain Capillaries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  D. Breimer,et al.  Glucocorticoid and type 1 interferon interactions at the blood–brain barrier: relevance for drug therapies for multiple sclerosis , 2001, Neuroreport.

[25]  Worth Andrew,et al.  Alternative (Non-Animal) Methods for Chemicals Testing: Current Status and Future Prospects (A Report Prepared by ECVAM and the ECVAM WG on Chemicals) , 2002 .

[26]  C. Meulenberg,et al.  Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. , 2000, Toxicology and applied pharmacology.

[27]  H. Galla,et al.  Tyrosine phosphatase inhibition induces loss of blood–brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways , 2004, Brain Research.

[28]  H. Kusuhara,et al.  Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). , 2001, Drug discovery today.

[29]  J B Houston,et al.  An Integrated Approach to the Prediction of Systemic Toxicity using Computer-based Biokinetic Models and Biological In vitro Test Methods: Overview of a Prevalidation Study Based on the ECITTS Project. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  N. Shaik,et al.  Drug efflux transporters in the CNS. , 2003, Advanced drug delivery reviews.

[31]  J. DeJongh,et al.  A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans , 1997, Archives of Toxicology.

[32]  J. Prins.  Directive 2003/98/EC of the European Parliament and of the Council , 2006 .

[33]  H. Tähti,et al.  Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum. , 2004, Toxicology and applied pharmacology.

[34]  L. Fenart,et al.  Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.

[35]  A. Gaillard,et al.  In Vitro Models of the Blood-Brain Barrier: When to Use Which? , 2002 .

[36]  M. Dehouck,et al.  Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture , 1989, Journal of neurochemistry.

[37]  C. Engelbertz,et al.  Porcine choroid plexus epithelial cells in culture: Regulation of barrier properties and transport processes , 2001, Microscopy research and technique.

[38]  H. Bauer,et al.  Neural Induction of the Blood–Brain Barrier: Still an Enigma , 2000, Cellular and Molecular Neurobiology.

[39]  G. Weinmaster,et al.  Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. , 2000, Microvascular research.

[40]  D. Begley,et al.  Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids , 2002, In Vitro Cellular & Developmental Biology - Animal.

[41]  I. Sherman,et al.  Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. , 1996, International journal for parasitology.

[42]  H. Drexler,et al.  Bladder carcinoma cell line ECV304 is not a model system for endothelial cells , 2002, In Vitro Cellular & Developmental Biology - Animal.

[43]  E. Walum,et al.  Determination of Critical Cellular Neurotoxic Concentrations in Human Neuroblastoma (SH-SY5Y) Cell Cultures , 1995 .

[44]  E. Hogan,et al.  Receptor‐Linked Hydrolysis of Phosphoinositides and Production of Prostacyclin in Cerebral Endothelial Cells , 1992, Journal of neurochemistry.

[45]  L. Devine,et al.  SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics , 1996, Journal of Neuroimmunology.

[46]  H. Takanaga,et al.  Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 , 2000, Journal of neurochemistry.

[47]  D. Breimer,et al.  Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. , 2003, Microvascular research.

[48]  R. Bendayan,et al.  Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.

[49]  J. Brillault,et al.  Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models , 2002, Pharmaceutical Research.

[50]  R. Monette,et al.  Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  C. Engelbertz,et al.  Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures , 2002, Cell and Tissue Research.

[52]  Meihua Rose Feng,et al.  Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo. , 2002, Current drug metabolism.

[53]  C. Lohmann,et al.  Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays , 2002, Journal of drug targeting.

[54]  H. Galla,et al.  Recent Advances in the Development of Cell Culture Models for the Blood-Brain- and Blood-CSF-Barrier , 2001 .

[55]  J. DeJongh,et al.  Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. , 1999, Toxicology and applied pharmacology.

[56]  B. Veronesi.  Characterization of the MDCK cell line for screening neurotoxicants. , 1996, Neurotoxicology.

[57]  S. Kajiji,et al.  P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. , 2001, The Journal of pharmacology and experimental therapeutics.

[58]  D. Janigro,et al.  Understanding the Physiology of the Blood-Brain Barrier: In Vitro Models. , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[59]  D. Mooradian,et al.  Production of a transforming growth factor-beta-like growth factor by RSV-transformed rat cerebral microvascular endothelial cells. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[60]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[61]  L. Fenart,et al.  Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier , 1998, Pharmaceutical Research.

[62]  H. Galla,et al.  Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier , 2003, Brain Research.

[63]  I. Tamai,et al.  Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies , 2004, Pharmaceutical Research.

[64]  R. Shivers,et al.  Immortalized mouse brain endothelial cells are ultrastructurally similar to endothelial cells and respond to astrocyte-conditioned medium , 1998, In Vitro Cellular & Developmental Biology - Animal.

[65]  T. Tsuruo,et al.  [Functional involvement of P-glycoprotein in blood-brain barrier]. , 1992, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[66]  N. Prasadarao,et al.  Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: Development of an immortalized cell line to study pathophysiology of CNS disease , 1997, In Vitro Cellular & Developmental Biology - Animal.

[67]  Thomas J. Raub,et al.  In vitro models of the blood-brain barrier. , 1998, Alternatives to laboratory animals : ATLA.

[68]  B. Blaauboer.  Biokinetic and Toxicodynamic Modelling and its Role in Toxicological Research and Risk Assessment , 2003, Alternatives to laboratory animals : ATLA.

[69]  C. Ringbom,et al.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[70]  Tarja Toimela,et al.  Refining In Vitro Neurotoxicity Testing — The Development of Blood–Brain Barrier Models , 2003, Alternatives to laboratory animals : ATLA.

[71]  H. Drexler,et al.  ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source , 1999, In Vitro Cellular & Developmental Biology - Animal.

[72]  H. Galla,et al.  Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro , 2003, Brain Research.